Differential Expression Analysis
FL14 / WBM Comparison
Note: The Fold Change value for up-regulated genes is displayed in red; down-regulated values are displayed in blue.
| Gene | Annotation | pval | Fold Change (log2ratio) |
|---|---|---|---|
| h19 | H19 fetal liver mRNA | 9.832e-8 | 5.909e+0 |
| xist | inactive X specific transcripts | 3.939e-3 | 5.123e+0 |
| ddx4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 9.225e-7 | 4.787e+0 |
| loc100047856 | similar to calponin 3, acidic | 1.430e-7 | 4.535e+0 |
| hbb-y | hemoglobin Y, beta-like embryonic chain | 3.638e-3 | 4.287e+0 |
| s100a16 | S100 calcium binding protein A16 | 8.231e-10 | 4.112e+0 |
| bc015286 | cDNA sequence BC015286 | 8.638e-8 | 4.104e+0 |
| igf2 | insulin-like growth factor 2 | 4.167e-5 | 3.832e+0 |
| hmga2 | high mobility group AT-hook 2 | 1.400e-9 | 3.565e+0 |
| cnn3 | calponin 3, acidic | 1.464e-6 | 3.539e+0 |
| expi | extracellular proteinase inhibitor | 4.832e-6 | 3.497e+0 |
| ottmusg00000000971 | predicted gene, OTTMUSG00000000971 | 9.345e-6 | 3.387e+0 |
| igf2bp1 | insulin-like growth factor 2 mRNA binding protein 1 | 1.043e-9 | 3.331e+0 |
| d0h4s114 | DNA segment, human D4S114 | 5.837e-8 | 3.301e+0 |
| id3 | inhibitor of DNA binding 3 | 1.855e-5 | 3.166e+0 |
| pik3r6 | phosphoinositide-3-kinase, regulatory subunit 6 | 7.160e-6 | 3.010e+0 |
| mpo | myeloperoxidase | 1.289e-5 | 2.979e+0 |
| igf2bp3 | insulin-like growth factor 2 mRNA binding protein 3 | 7.888e-8 | 2.967e+0 |
| acp5 | acid phosphatase 5, tartrate resistant | 2.652e-5 | 2.948e+0 |
| dkk1 | dickkopf homolog 1 (Xenopus laevis) | 2.425e-9 | 2.884e+0 |
| gem | GTP binding protein (gene overexpressed in skeletal muscle) | 1.872e-5 | 2.817e+0 |
| tsix | X (inactive)-specific transcript, antisense | 2.652e-3 | 2.808e+0 |
| bank1 | B-cell scaffold protein with ankyrin repeats 1 | 3.809e-5 | 2.803e+0 |
| postn | periostin, osteoblast specific factor | 5.151e-6 | 2.775e+0 |
| col18a1 | collagen, type XVIII, alpha 1 | 1.531e-8 | 2.604e+0 |
| clec4e | C-type lectin domain family 4, member e | 6.227e-6 | 2.551e+0 |
| d2ertd173e | DNA segment, Chr 2, ERATO Doi 173, expressed | 1.182e-4 | 2.544e+0 |
| 2610528g24rik | RIKEN cDNA 2610528G24 gene | 3.259e-7 | 2.540e+0 |
| rasgrp3 | RAS, guanyl releasing protein 3 | 9.677e-6 | 2.496e+0 |
| 2010001m09rik | RIKEN cDNA 2010001M09 gene | 6.417e-3 | 2.468e+0 |
| dlk1 | delta-like 1 homolog (Drosophila) | 6.872e-6 | 2.450e+0 |
| igf2bp2 | insulin-like growth factor 2 mRNA binding protein 2 | 5.425e-8 | 2.423e+0 |
| d430019h16rik | RIKEN cDNA D430019H16 gene | 2.462e-7 | 2.416e+0 |
| 6330403k07rik | RIKEN cDNA 6330403K07 gene | 5.696e-6 | 2.401e+0 |
| ndrg4 | N-myc downstream regulated gene 4 | 7.820e-6 | 2.374e+0 |
| grap | GRB2-related adaptor protein | 4.424e-5 | 2.359e+0 |
| tspan6 | tetraspanin 6 | 8.197e-7 | 2.289e+0 |
| adm | adrenomedullin | 4.612e-4 | 2.284e+0 |
| spats2 | spermatogenesis associated, serine-rich 2 | 5.870e-6 | 2.250e+0 |
| tyrobp | TYRO protein tyrosine kinase binding protein | 2.023e-4 | 2.238e+0 |
| gfi1 | growth factor independent 1 | 2.567e-5 | 2.218e+0 |
| acbd7 | acyl-Coenzyme A binding domain containing 7 | 1.309e-4 | 2.218e+0 |
| d930028f11rik | RIKEN cDNA D930028F11 gene | 3.233e-4 | 2.218e+0 |
| sh3gl3 | SH3-domain GRB2-like 3 | 1.947e-7 | 2.207e+0 |
| cxcr3 | chemokine (C-X-C motif) receptor 3 | 1.332e-4 | 2.201e+0 |
| d10ertd755e | DNA segment, Chr 10, ERATO Doi 755, expressed | 1.983e-3 | 2.173e+0 |
| bex6 | brain expressed gene 6 | 4.956e-4 | 2.146e+0 |
| lgals1 | lectin, galactose binding, soluble 1 | 7.739e-6 | 2.138e+0 |
| dok2 | docking protein 2 | 2.634e-6 | 2.130e+0 |
| asprv1 | aspartic peptidase, retroviral-like 1 | 1.467e-6 | 2.121e+0 |
| ube2c | ubiquitin-conjugating enzyme E2C | 2.995e-5 | 2.100e+0 |
| msrb3 | methionine sulfoxide reductase B3 | 8.066e-4 | 2.077e+0 |
| zfp711 | zinc finger protein 711 | 6.870e-4 | 2.058e+0 |
| cyp4b1 | cytochrome P450, family 4, subfamily b, polypeptide 1 | 9.411e-7 | 2.050e+0 |
| tnnt1 | troponin T1, skeletal, slow | 1.109e-6 | 2.040e+0 |
| 2810417h13rik | RIKEN cDNA 2810417H13 gene | 2.338e-6 | 2.027e+0 |
| tnfrsf25 | tumor necrosis factor receptor superfamily, member 25 | 1.191e-5 | 2.020e+0 |
| a830059i20rik | RIKEN cDNA A830059I20 gene | 6.847e-7 | 2.011e+0 |
| ear2 | eosinophil-associated, ribonuclease A family, member 2 | 3.636e-3 | -2.002e+0 |
| tmem40 | transmembrane protein 40 | 1.827e-6 | -2.017e+0 |
| nupr1 | nuclear protein 1 | 4.536e-4 | -2.023e+0 |
| ccl19 | chemokine (C-C motif) ligand 19 | 2.017e-5 | -2.034e+0 |
| 2900084o13rik | RIKEN cDNA 2900084O13 gene | 6.386e-4 | -2.036e+0 |
| nckap1 | NCK-associated protein 1 | 8.819e-5 | -2.073e+0 |
| casp1 | caspase 1 | 9.335e-6 | -2.074e+0 |
| abcb1a | ATP-binding cassette, sub-family B (MDR/TAP), member 1A | 8.319e-5 | -2.083e+0 |
| sdpr | serum deprivation response | 2.417e-3 | -2.087e+0 |
| col16a1 | collagen, type XVI, alpha 1 | 7.844e-9 | -2.112e+0 |
| slc16a12 | solute carrier family 16 (monocarboxylic acid transporters), member 12 | 1.279e-2 | -2.120e+0 |
| e130304f04rik | RIKEN cDNA E130304F04 gene | 7.612e-5 | -2.122e+0 |
| gbp2 | guanylate binding protein 2 | 2.615e-5 | -2.130e+0 |
| foxa3 | forkhead box A3 | 1.683e-6 | -2.141e+0 |
| klf9 | Kruppel-like factor 9 | 1.599e-4 | -2.150e+0 |
| bhlhb2 | basic helix-loop-helix domain containing, class B2 | 5.504e-5 | -2.166e+0 |
| ms4a6c | membrane-spanning 4-domains, subfamily A, member 6C | 2.496e-4 | -2.166e+0 |
| perp | PERP, TP53 apoptosis effector | 1.289e-3 | -2.169e+0 |
| sox6 | SRY-box containing gene 6 | 2.034e-7 | -2.175e+0 |
| 2310043n10rik | RIKEN cDNA 2310043N10 gene | 1.515e-3 | -2.196e+0 |
| hdgfrp3 | hepatoma-derived growth factor, related protein 3 | 3.571e-6 | -2.223e+0 |
| tnfsf4 | tumor necrosis factor (ligand) superfamily, member 4 | 9.739e-5 | -2.227e+0 |
| h2-dmb1 | histocompatibility 2, class II, locus Mb1 | 4.638e-5 | -2.237e+0 |
| nfia | nuclear factor I/A | 3.155e-4 | -2.258e+0 |
| oas3 | 2'-5' oligoadenylate synthetase 3 | 2.636e-4 | -2.272e+0 |
| 2310051e17rik | RIKEN cDNA 2310051E17 gene | 2.199e-8 | -2.286e+0 |
| eg381438 | predicted gene, EG381438 | 2.560e-5 | -2.289e+0 |
| cyp2j6 | cytochrome P450, family 2, subfamily j, polypeptide 6 | 1.848e-4 | -2.317e+0 |
| rai2 | retinoic acid induced 2 | 1.956e-4 | -2.321e+0 |
| tgtp | T-cell specific GTPase | 6.427e-6 | -2.344e+0 |
| h2-dma | histocompatibility 2, class II, locus DMa | 2.169e-7 | -2.346e+0 |
| c1r | complement component 1, r subcomponent | 1.158e-6 | -2.366e+0 |
| casp12 | caspase 12 | 1.980e-5 | -2.377e+0 |
| calml4 | calmodulin-like 4 | 2.753e-4 | -2.383e+0 |
| galnt6 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 | 2.604e-6 | -2.384e+0 |
| upp1 | uridine phosphorylase 1 | 8.117e-6 | -2.496e+0 |
| plscr2 | phospholipid scramblase 2 | 4.466e-4 | -2.505e+0 |
| nkg7 | natural killer cell group 7 sequence | 2.898e-5 | -2.506e+0 |
| clec2d | C-type lectin domain family 2, member d | 3.321e-4 | -2.525e+0 |
| lhcgr | luteinizing hormone/choriogonadotropin receptor | 1.421e-5 | -2.558e+0 |
| npdc1 | neural proliferation, differentiation and control gene 1 | 3.333e-5 | -2.560e+0 |
| 2210023g05rik | RIKEN cDNA 2210023G05 gene | 1.258e-4 | -2.571e+0 |
| mdfic | MyoD family inhibitor domain containing | 2.092e-6 | -2.577e+0 |
| ptger4 | prostaglandin E receptor 4 (subtype EP4) | 1.168e-5 | -2.588e+0 |
| tacstd2 | tumor-associated calcium signal transducer 2 | 7.670e-6 | -2.616e+0 |
| plscr4 | phospholipid scramblase 4 | 5.358e-7 | -2.616e+0 |
| cd74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 5.251e-6 | -2.617e+0 |
| gpx7 | glutathione peroxidase 7 | 7.818e-6 | -2.627e+0 |
| 6330403m23rik | RIKEN cDNA 6330403M23 gene | 1.081e-5 | -2.637e+0 |
| ltbp3 | latent transforming growth factor beta binding protein 3 | 3.629e-8 | -2.656e+0 |
| aw112010 | expressed sequence AW112010 | 1.213e-6 | -2.668e+0 |
| kazald1 | Kazal-type serine peptidase inhibitor domain 1 | 2.911e-5 | -2.726e+0 |
| iigp1 | interferon inducible GTPase 1 | 2.535e-6 | -2.744e+0 |
| muc13 | mucin 13, epithelial transmembrane | 7.369e-7 | -2.761e+0 |
| ndrg1 | N-myc downstream regulated gene 1 | 3.399e-6 | -2.775e+0 |
| ensmusg00000055440 | predicted gene, ENSMUSG00000055440 | 5.713e-6 | -2.820e+0 |
| pqlc3 | PQ loop repeat containing | 5.596e-6 | -2.823e+0 |
| fos | FBJ osteosarcoma oncogene | 9.909e-3 | -2.837e+0 |
| h2-eb1 | histocompatibility 2, class II antigen E beta | 1.642e-7 | -2.902e+0 |
| fbp1 | fructose bisphosphatase 1 | 3.739e-5 | -2.924e+0 |
| cd72 | CD72 antigen | 6.756e-7 | -2.947e+0 |
| ripply3 | ripply3 homolog (zebrafish) | 3.087e-8 | -2.953e+0 |
| nlrc5 | NLR family, CARD domain containing 5 | 3.745e-6 | -2.975e+0 |
| mylc2pl | myosin light chain 2, precursor lymphocyte-specific | 6.977e-4 | -2.982e+0 |
| d630039a03rik | RIKEN cDNA D630039A03 gene | 4.958e-7 | -3.042e+0 |
| alcam | activated leukocyte cell adhesion molecule | 1.040e-8 | -3.061e+0 |
| slc6a15 | solute carrier family 6 (neurotransmitter transporter), member 15 | 1.762e-5 | -3.074e+0 |
| csgalnact1 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | 6.171e-7 | -3.101e+0 |
| lair1 | leukocyte-associated Ig-like receptor 1 | 1.590e-7 | -3.129e+0 |
| bgn | biglycan | 4.921e-9 | -3.133e+0 |
| mpa2l | macrophage activation 2 like | 2.860e-5 | -3.163e+0 |
| esr1 | estrogen receptor 1 (alpha) | 6.950e-8 | -3.257e+0 |
| 5830443l24rik | RIKEN cDNA 5830443L24 gene | 2.135e-5 | -3.272e+0 |
| a730056i06rik | RIKEN cDNA A730056I06 gene | 4.223e-9 | -3.283e+0 |
| car1 | carbonic anhydrase 1 | 7.063e-5 | -3.306e+0 |
| serpinb1a | serine (or cysteine) peptidase inhibitor, clade B, member 1a | 1.334e-7 | -3.383e+0 |
| cadps2 | Ca2+-dependent activator protein for secretion 2 | 9.484e-7 | -3.397e+0 |
| ngp | neutrophilic granule protein | 2.396e-4 | -3.458e+0 |
| cpne2 | copine II | 7.037e-8 | -3.471e+0 |
| 1100001g20rik | RIKEN cDNA 1100001G20 gene | 5.425e-4 | -3.573e+0 |
| clec1a | C-type lectin domain family 1, member a | 3.636e-6 | -3.650e+0 |
| h2-aa | histocompatibility 2, class II antigen A, alpha | 6.111e-7 | -3.661e+0 |
| egr1 | early growth response 1 | 2.026e-6 | -3.751e+0 |
| sdsl | serine dehydratase-like | 9.781e-8 | -3.850e+0 |
| rmcs5 | response to metastatic cancers 5 | 7.056e-8 | -3.977e+0 |
| h2-gs10 | MHC class I like protein GS10 | 5.454e-7 | -4.112e+0 |
| igj | immunoglobulin joining chain | 3.440e-2 | -4.329e+0 |
| camp | cathelicidin antimicrobial peptide | 7.742e-5 | -4.335e+0 |
| tnfsf13 | tumor necrosis factor (ligand) superfamily, member 13 | 4.758e-5 | -4.351e+0 |
| ctss | cathepsin S | 6.991e-7 | -4.460e+0 |
| gda | guanine deaminase | 9.578e-8 | -4.570e+0 |
| sult1a1 | sulfotransferase family 1A, phenol-preferring, member 1 | 8.395e-7 | -4.575e+0 |
| chi3l3 | chitinase 3-like 3 | 5.870e-7 | -4.757e+0 |
| h2-q8 | histocompatibility 2, Q region locus 8 | 5.211e-7 | -4.861e+0 |
| 4930519l02rik | RIKEN cDNA 4930519L02 gene | 2.218e-6 | -5.230e+0 |
| rgs1 | regulator of G-protein signaling 1 | 1.589e-9 | -5.472e+0 |
| h2-q7 | histocompatibility 2, Q region locus 7 | 7.706e-10 | -5.884e+0 |
| s100a8 | S100 calcium binding protein A8 (calgranulin A) | 2.292e-6 | -5.976e+0 |
| 0610037m15rik | RIKEN cDNA 0610037M15 gene | 4.593e-9 | -6.057e+0 |
| s100a9 | S100 calcium binding protein A9 (calgranulin B) | 5.749e-6 | -6.137e+0 |
| aldh1a1 | aldehyde dehydrogenase family 1, subfamily A1 | 1.821e-7 | -6.286e+0 |